about
Antiviral prophylaxis in patients with solid tumours and haematological malignancies--update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO)Stenotrophomonas maltophilia: an emerging global opportunistic pathogenImmunomodulatory effects of low dose chemotherapy and perspectives of its combination with immunotherapyRegulation of Pseudomonas aeruginosa Virulence by Distinct Iron SourcesThe regulatory repertoire of Pseudomonas aeruginosa AmpC ß-lactamase regulator AmpR includes virulence genesRadiation-Induced Organizing Pneumonia: A Characteristic Disease that Requires Symptom-Oriented ManagementA human surfactant peptide-elastase inhibitor construct as a treatment for emphysema.Panax ginseng modulates cytokines in bone marrow toxicity and myelopoiesis: ginsenoside Rg1 partially supports myelopoiesisClinical outcomes of extracorporeal membrane oxygenation support in patients with hematologic malignancies.Pseudomonas aeruginosa AmpR: an acute-chronic switch regulator.Ceftriaxone, an FDA-approved cephalosporin antibiotic, suppresses lung cancer growth by targeting Aurora B.Retrospective analysis of the microbiological spectrum of pneumonia in Turkish patients with lung cancerEarly warning and prevention of pneumonia in acute leukemia by patient education, spirometry, and positive expiratory pressure: A randomized controlled trial.Exogenous remodeling of lung resident macrophages protects against infectious consequences of bone marrow-suppressive chemotherapy.Utility of bronchoalveolar lavage in the diagnosis of pulmonary infection in children with haematological malignancies.Ethical and clinical aspects of intensive care unit admission in patients with hematological malignancies: guidelines of the ethics commission of the French society of hematology.Corchorusin-D directed apoptosis of K562 cells occurs through activation of mitochondrial and death receptor pathways and suppression of AKT/PKB pathway.Bacterial Pneumonia in Patients with Cancer: Novel Risk Factors and Management.Chemomodulation of human dendritic cell function by antineoplastic agents in low noncytotoxic concentrationsThe Pseudomonas aeruginosa PrrF Small RNAs Regulate Iron Homeostasis during Acute Murine Lung Infection.Blue light treatment of Pseudomonas aeruginosa: Strong bactericidal activity, synergism with antibiotics and inactivation of virulence factorsManagement of Acute Respiratory Failure in Patients With Hematological Malignancy.The Effect of Silver Nanoparticles Size, Produced Using Plant Extract from Arbutus unedo, on Their Antibacterial EfficacySpoils of war: iron at the crux of clinical and ecological fitness of Pseudomonas aeruginosa.Inducible epithelial resistance protects mice against leukemia-associated pneumonia.Bacterial pneumonia following cytotoxic chemotherapy for lung cancer: clinical features, treatment outcome and prognostic factors.The role of bacterial culture by bronchoscopy in patients with lung cancer: a prospective study.Severe hepatic abscess: Conservative treatment of multi-organ infection by Stenotrophomonas maltophilia. A case reportCytotoxic chemotherapy reduces T cell trafficking to the spleen by downregulating the expression of C-C motif chemokine ligand 21 and C-C motif chemokine ligand 19
P2860
Q26801716-81F6048A-6C62-4689-A990-AC9740148822Q26995336-0EE19247-0B38-4FD6-953F-0019C4A51262Q27027093-7C1EC581-806B-47BB-B8E7-8ACF67112691Q28066690-65E7D7B9-BC2D-456D-8780-DC47F31550F5Q28493156-0C30C64C-88DF-4162-8931-2B989C9DE8EDQ30238723-5BF39B4B-D250-4810-9683-1B34AD48CC09Q33934859-309909DC-89FC-4563-920A-1363DA872AAFQ34241632-CCF39007-0ABA-457C-B852-AC4020A4B095Q35834945-10E95048-964D-4E71-B1BC-EB237958E17FQ35975439-43E7C45B-1096-4BCC-94B2-78333EDA3789Q36435773-329525E3-5D59-4933-9B7B-3D7CBD03EEDEQ36792893-42493495-7431-4469-B684-8B7B55BE7085Q37345664-7A720550-D98E-4E11-968B-B6F1205CBA56Q37346941-863AE9C8-6E00-4EA3-BEC2-CAEA4C6CE8A0Q38043967-8CBCAC2D-1CA3-4676-9355-B7057E86E5D4Q38263189-57922D1A-CAAA-4D31-971B-52A16158ED8EQ39281521-72E0D551-04BC-46F0-B2C5-E21F6013853DQ39287519-218B84C7-720D-4F6B-8907-F17155763AF8Q39826691-191C9D71-79C7-4ADD-8AC5-72FF8FE36A4EQ40295897-63563962-4AFB-498B-B112-B9AC794947CEQ40496805-93B5FD6A-DF03-4772-8AC4-6DEF9A802E8DQ41047392-3A8E1883-51AF-449D-A0F5-1A6272FF5110Q41175792-79208682-8F11-4C60-AE15-69DE1592589BQ41407638-7508FBD4-2F6C-499E-A75B-8D04E509F0C1Q41563226-86E7112C-A500-4BE1-8E20-C3FA12D6E3FCQ44707933-C40BF097-D175-4FBD-BBD7-F078F24E0046Q47177129-5CC4BE27-B8D5-4584-A1E1-16B7E168B120Q58761233-85AE5903-DA3F-45DD-A04F-CC4E455B0289Q58792079-69DF982A-D78F-48AD-8F71-A9AE3195EADC
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Lung infections after cancer chemotherapy.
@en
Lung infections after cancer chemotherapy.
@nl
type
label
Lung infections after cancer chemotherapy.
@en
Lung infections after cancer chemotherapy.
@nl
prefLabel
Lung infections after cancer chemotherapy.
@en
Lung infections after cancer chemotherapy.
@nl
P1433
P1476
Lung infections after cancer chemotherapy.
@en
P2093
Zelalem Temesgen
P304
P356
10.1016/S1470-2045(08)70255-9
P577
2008-10-01T00:00:00Z